Wu Zhen (politician)
| Wu Zhen | |
|---|---|
| 吴浈 | |
| Deputy Commissioner of the National Health and Family Planning Commission | |
|
In office August 2015 – March 2018 | |
| Deputy Director of the China Food and Drug Administration | |
|
In office July 2013 – March 2018 | |
| Personal details | |
| Born |
May 1958 (age 60) Nanfeng County, Jiangxi |
| Political party | Communist Party of China |
| Alma mater | Jiangxi University of Traditional Chinese Medicine |
Wu Zhen (Chinese: 吴浈; pinyin: Wú Zhēn; born May 1958) is a former Chinese politician who served as the Deputy Commissioner of the National Health and Family Planning Commission and the Deputy Director of the China Food and Drug Administration. He was dismissed from his position in August 2018 and placed under investigation by the Central Commission for Discipline Inspection and the National Supervisory Commission.
Career
Wu was born in May 1958, and he was graduated from Jiangxi University of Traditional Chinese Medicine in 1983.[1] He served as the officer of the Medical Education Science and Technology Department of the Health Department of Jiangxi, the director of the Drug Administration of the Health Department of Jiangxi, and the director of the Jiangxi Food and Drug Administration.[2][3]
In 2006, Wu was appointed as the deputy director of the State Food and Drug Administration, who was responsible for drug registration, supervision and review. He was appointed as the Director of Food and Drug Safety of the China Food and Drug Administration in April 2013, then he appointed as the deputy director in July. Wu also served as the Deputy Commissioner of the National Health and Family Planning Commission since 2015, and he retired in 2018.[2][3]
Wu was dubbed a “vaccine tsar”, which he was responsible for vaccine supervision for long time.[3]
Investigation
On August 16, 2018, Wang Tie was placed under investigation by the Central Commission for Discipline Inspection, the party's internal disciplinary body, and the National Supervisory Commission, the highest anti-corruption agency of the People's Republic of China. According the report, this announcement was decided by the meeting of the Politburo Standing Committee of the Communist Party of China. [4]
References
- ↑ "问题疫苗习李震怒 揭秘落马副部官员非正常升迁". DW News. Retrieved 2018-09-20.
- 1 2 "中国"疫苗沙皇"吴浈分管疫苗期间大案频发". DW News. Retrieved 2018-08-19.
- 1 2 3 ""疫苗沙皇"被查 曾被记者实名举报". The Beijing News. Retrieved 2018-08-19.
- ↑ "中共中央政治局常务委员会召开会议 听取关于吉林长春长生公司问题疫苗案件调查及有关问责情况的汇报 中共中央总书记习近平主持会议". 新华网. Retrieved 2018-08-16.